Table 2. Adverse event.
| Adverse events | Grade 1, n (%) | Grade 2, n (%) | Grade 3, n (%) |
|---|---|---|---|
| Paresthesia | 37 (35.9) | 19 (18.4) | 2 (1.9) |
| Muscle cramping | 22 (21.4) | 2 (1.9) | – |
| Rash | 18 (17.5) | 9 (8.7) | 2 (1.9) |
| Bilirubin elevation | – | – | 1 (1.0) |
| Diarrhea | 15 (14.6) | 2 (1.9) | – |
| Pruritus | 13 (12.6) | 5 (4.9) | – |
| Headache | 10 (9.7) | 3 (2.9) | – |
| Fatigue | 6 (5.8) | 6 (5.8) | – |
| Anorexia | 4 (3.9) | 5 (4.9) | – |
| Nausea | 5 (4.9) | 2 (1.9) | – |
| Dizziness | 6 (5.8) | 1 (1.0) | – |
| Edema | 4 (3.9) | 1 (1.0) | – |
| Nail change | 3 (2.9) | 1 (1.0) | – |
| Mucositis | 3 (2.9) | 1 (1.0) | – |
| Pneumonitis | 1 (1.0) | 1 (1.0) | – |
| Myalgia | 7 (6.8) | – | – |
| AST/ALT elevation | 2 (1.9) | – | – |
AST, aspartate aminotransferase; ALT, alanine aminotransferase.